|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.43 BRL | -8.77% |
|
-6.44% | -42.47% |
| 08/05 | Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 07/05 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Blau Farmacêutica S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was BRL 359.68 million compared to BRL 258.2 million a year ago. Net income was BRL 40.09 million compared to BRL 51.95 million a year ago.
Basic earnings per share from continuing operations was BRL 0.2256 compared to BRL 0.29 a year ago. Diluted earnings per share from continuing operations was BRL 0.2256 compared to BRL 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.47% | 314M | |
| +52.32% | 803B | |
| -6.10% | 351B | |
| +18.64% | 324B | |
| +11.10% | 303B | |
| +16.96% | 243B | |
| +2.25% | 228B | |
| +11.15% | 217B | |
| +7.17% | 164B | |
| -3.09% | 155B |
BLAU FARMACÊUTICA S.A. 
